Differential regulation of serum microRNA expression by HNF1β and HNF1α transcription factors

Abstract

Aims/hypothesisWe aimed to identify microRNAs (miRNAs) under transcriptional control of the HNF1β transcription factor, and investigate whether its effect manifests in serum.MethodsThe Polish cohort (N = 60) consisted of 11 patients with HNF1B-MODY, 17 with HNF1A-MODY, 13 with GCK-MODY, an HbA1c-matched type 1 diabetic group (n = 9) and ten healthy controls. Replication was performed in 61 clinically-matched British patients mirroring the groups in the Polish cohort. The Polish cohort underwent miRNA serum level profiling with quantitative real-time PCR (qPCR) arrays to identify differentially expressed miRNAs. Validation was performed using qPCR. To determine whether serum content reflects alterations at a cellular level, we quantified miRNA levels in a human hepatocyte cell line (HepG2) with small interfering RNA knockdowns of HNF1α or HNF1β.ResultsSignificant differences (adjusted p < 0.05) were noted for 11 miRNAs. Five of them differed between HNF1A-MODY and HNF1B-MODY, and, amongst those, four (miR-24, miR-27b, miR-223 and miR-199a) showed HNF1B-MODY-specific expression levels in the replication group. In all four cases the miRNA expression level was lower in HNF1B-MODY than in all other tested groups. Areas under the receiver operating characteristic curves ranged from 0.79 to 0.86, with sensitivity and specificity reaching 91.7% (miR-24) and 82.1% (miR-199a), respectively. The cellular expression pattern of miRNA was consistent with serum levels, as all were significantly higher in HNF1α- than in HNF1β-deficient HepG2 cells.Conclusions/interpretationWe have shown that expression of specific miRNAs depends on HNF1β function. The impact of HNF1β deficiency was evidenced at serum level, making HNF1β-dependent miRNAs potentially applicable in the diagnosis of HNF1B-MODY.Electronic supplementary materialThe online version of this article (doi:10.1007/s00125-016-3945-0) contains peer-reviewed but unedited supplementary material, which is available to authorised users.

Evolutionarily conserved serum microRNAs predict radiation-induced fatality in nonhuman primates

“…MiRNA profiling was performed as described previously (11, 25) using quantitative PCR panels from Exiqon with LNA-modified primers. PCR panels are accurate and convergent with miRNA sequencing data, provided that the number of copies of a miRNA exceeds 10 per million (26).…”

Temporal dynamics of serum let‐7g expression mirror the decline of residual beta‐cell function in longitudinal observation of children with type 1 diabetes

“…Two separate study groups were used in the study. The first one (profiling cohort) was a reanalysis of published microRNA profiling data focused on the differences between HbA1c‐matched T1DM patients established diabetes controls, and patients with GCK‐MODY. This experimental setup was chosen to identify miRNAs linked with hyperglycemia with or without autoimmunity.…”

“…Nominal variables were presented as numbers with appropriate percentage. From profiling experiment only miRNAs detectable in more than 50% of serum samples from the three compared groups (T1DM, controls, and GCK‐MODY) entered further statistical testing procedure. After normalization, miRNA levels were compared using one‐way ANOVA with Benjamini‐Hochberg procedure used to calculate false discovery rates (FDRs) to account for multiple comparisons.…”

“…miR‐146a was described as prevalently expressed in regulatory T cells and was implicated in their function by directly targeting transcription factor key (Stat1) for Th1 differentiation and interferon gamma (IFN‐γ) response . Altered miR‐24 levels were also previously reported in serum in T1DM patients and in plasma in T2DM patients . In a study investigating plasma miRNA profile of T1DM patients, several miRNAs, including miR‐375, miR‐146a, and miR‐24, were associated with residual beta‐cell function and glycemic control in short time after T1DM diagnosis …”

Plasma microRNA detection standardization test

“…Alternatively, this could have occurred because the increase in plasma volume introduces excessive contaminants (highly variable plasma matrix, lipid, or plasma protein), which interferes with the purification process, as often occurs in clinical samples. Won reported that in the absence of a reliable method of miRNA isolation from plasma, selection of an appropriate internal or external parameter can reduce variation in results due to detection factors . In this experiment, we introduced internal and external references to calibrate the results and found that using internal parameters reduces this variation considerably.…”